Global In-Vitro Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025

The In-Vitro Diagnostics Market is anticipated to gain the market worth of US$ 98.2 billion by 2025, expanding at a CAGR of 5.24% during the forecast period 2019-2025. The major reasons that would escalate the adoption of In-Vitro Diagnostics are increasing prevalence of chronic diseases, rising geriatric population and increasing adoption of Point-of-Care diagnosis techniques. Moreover, changing reimbursement models and regulations, investing in unifying technology, consolidation and automation of labs, shift to data-driven healthcare would mark as a trend in this industry. In-vitro diagnostics (IVDs) play a critical role in driving clinical decision-making and their true impact includes cost savings and increased efficiencies in downstream activities. IVD testing can answer crucial questions about a patient’s health status, including risk or predisposition for developing a certain condition; stage of disease; chances of therapy response; and prognosis for progression/remission under therapy. Evidence suggests that the potential of IVDs is currently underexploited and undervalued. Recent research indicates that IVDs account for 2.3% and 1.4% of total healthcare expenditure in the US and Germany respectively while driving 66% of clinical decision-making. The reagents segment generated revenue of US$ 47.5 billion in 2018, owing to the recent advancements in IVD instruments and growth in demand for fully automated instruments in market.

Request for Sample of the report - https://univdatos.com/request_form/form/237

The growth in the number of public and private diagnostic centers and point-of-care testing centers is expected to fuel growth to the global in-vitro diagnostics market in years to come. Healthcare organizations continue to be challenged with escalating costs and decreased funding, which makes it even more difficult to deliver quality services to a broad patient population. In order to control costs while maintaining a high quality of care, providers are looking to generate efficiency gains, eliminate waste, optimize processes and drive appropriate utilization of resources among others. Chronic diseases are a growing global challenge, and according to WHO estimates, account for approximately 60% of all deaths, worldwide. Hence, an increasing number of Chronic patients demand or In-Vitro Diagnostic technology would increase. Patients are becoming more comfortable with digital devices and services; hence healthcare stakeholders are investing in digital strategies to increase efficiency and improve the cost-effectiveness of their business and offerings. Integration of technology in labs and hospitals are driving clinicians, data analysts, and corporate leaders, among others, to extract meaningful information from data to deliver higher-quality, more coordinated healthcare services. Accountable care organizations and laboratories emphasize diagnostic testing integrated with hospital systems to harness data while monitoring individual patients. Healthcare is the basic requirement of all the individuals, however, the high cost of the healthcare service makes it difficult for the low and low-middle class individuals to afford the same. The route to funding and financial aid is extraordinarily complex. Aging leads to deteriorating health due to impairment and thus leads to huge expenditure on it. IVD companies tend to share technologies rather than compete against one another to produce bundled tests, improving the patient care continuum. Technological convergence is bound to increase volume as more patients opt for bundled packages.

Feel free to contact us for any queries - https://univdatos.com/request_form/form/237

Based on Product type the global in-vitro diagnostics market is segmented into reagents and Instruments Services. The market of The reagents segment is expected to grow tremendously and is projected to dominate the market in 2025 due to its high demand in over-the-counter diagnostic tests, paired with rising demand for these for tests at non-medical facilities such as a home. Based on techniques the global In-Vitro Diagnostics market is segmented into Immunoassay, Clinical Chemistry, SMBG, Molecular Diagnostics, Hematology, Microbiology, Point-of-Care and Hemostasis. The Immunoassay technique occupied the largest share of 24.7% in 2018. Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases are the major applications of In-Vitro Diagnostics technology. In 2018, IVD was majorly used for the treatment and diagnosis of Infectious Diseases. The segment is expected to witness CAGR 4.89% during the forecast period 2019-2025. In 2018, the hospital segment occupied 47.6% share. However, the use of technology for home disease treatment is expected to witness the highest CAGR growth dusting the forecast period 2019-2025. In addition, The Reusable IVD Devices occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025.

For Regional/country-wise analysis of the overall adoption of In-Vitro Diagnostics technology in different healthcare facilities browse through – In-Vitro Diagnostics Market

For a deep-dive analysis of the industry and its adoption rate, detailed regional/country-level analysis was conducted for regions including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, UK and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of the World (Brazil and Others). In 2018, North America dominated the market, however the growing elderly population in Europe and Asia-Pacific would help the region to use more of in-vitro diagnostic technology for disease detection and treatment. Some of the major companies profiled in the global In-Vitro Diagnostics study include Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, Roche, Siemens Healthineers AG, Sysmex Corporation and Thermo Fisher Scientific. These industry players are entering into partnerships and mergers & acquisitions for the expansion of their reach and proving older populations with better services. Some of the key players are also expanding their businesses by setting up new elder care homes and community centers or increasing their expenditure on R&D. 

Global In-Vitro Diagnostics Market Segmentation

Market Insights, by Product Type
Reagents
Instruments Services

Market Insights, by Technique
Immunoassay
Clinical Chemistry
SMBG
Molecular Diagnostics
Hematology
Microbiology
Point-of-Care
Hemostasis

Market Insights, by Application
Infectious Disease
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Disease
Others

Market Insights, by End User
Hospitals
Clinics & Labs
Home Care
Others

Market Insights, by Usability
Disposable IVD Devices
Reusable IVD Devices

The Global In-Vitro Diagnostics Market can be customized to the country level or any other market segment. Besides this, UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients.

Dietary Supplements Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020-2026

Artificial Iris Market — Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020–2026

Smart Inhalers Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020-2026

Molecular Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025

UnivDatos Market Insights (UMI)

Email: sales@univdatos.com

Molecular Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025

The Molecular Diagnostics Market is anticipated to gain the market worth of US$ 9.5 billion by 2025, expanding at a CAGR of 6.3% during the forecast period 2019-2025. The major reasons that will escalate the adoption of molecular diagnostics are a high prevalence of infectious diseases and cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. The growing incidence of infectious diseases and cancer awareness programs, progress in biomarker identification, acceptance of personalized medicines would further drive the market growth over the forecast period. Additionally, a rise in occurrence rates of cardiovascular disorders, genetic disorders, neurological disorders is also expected to fuel market growth. Moreover, changing reimbursement models and regulations, investing in unifying technology, consolidation and automation of labs would mark as the major trend in the industry. The high prices of molecular diagnostics tests and unfavorable reimbursement policies will act as the major restraints in the growth of this market.

To analyze the ongoing and projected development under the healthcare diagnostic sector browse through - https://univdatos.com/report/molecular-diagnostics-market-current-scenario-and-forecast-2019-2025

Healthcare expenditure as a proportion of gross domestic product (GDP) is on the rise. In the US, healthcare spending is expected to grow 1.3% points faster than GDP annually, rising to comprise 20.1% of GDP by 2025. This will lead to the rise in the entry of players and this domain and will affect the molecular diagnostics market. The concept of clinical validity and utility underpins the use of molecular diagnostic tests in the clinical laboratory, and continuous sharing of expertise between clinical and laboratory partners will enhance the appropriateness of molecular testing and interpretation, thus improving personalized medicine. Thanks to the technological advances made in molecular diagnostics, above all in next-generation sequencing (NGS) and digital polymerase chain reaction (dPCR) platforms, clinical laboratories benefit from the rapid translation of established and emerging molecular tests. Advancing molecular diagnostics has been the prime agenda of biomedical scientists around the globe. Molecular diagnostics has made possible the diagnosis of the previously undetected viral nucleic acids and helped provide a deeper understanding of the cause of disease, treatment dose, and success of the treatment depending upon the case. It has provided an immense scope of the novel and more sophisticated biotechnology and biomedical tools to be employed in this sector procreating a new interdisciplinary field. Increasing R&D activities focused on developing advanced tools and techniques intended to enable rapid as well as accurate diagnosis of disease will propel molecular diagnostics’ market growth. As the demand for early diagnosis of these diseases is high, various public and private organizations are investing funds to accelerate R&D in the field of molecular diagnostics.

Request for Sample of the report - https://univdatos.com/request_form/form/239 

Based on product type the global molecular diagnostics market is bifurcated into Instruments, Reagents and services and others. The market of the Reagents segment is expected to grow tremendously and is projected to dominate the market in 2025. Molecular diagnostics market, based on technique is segmented into Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays and others. The PCR segment occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025 owing to the increased usage and advancements in PCR techniques. In 2018, PCR dominated the global molecular diagnostics technology type market and is anticipated to generate a market size of US$ 3,508.8 million by 2025. In 2018, the Virology application segment dominated the market and is anticipated to dominate this segment in 2025. However, the Oncology application segment is expected to witness the highest CAGR of 8.27% during the forecast period 2019-2025. Hospitals, clinics & labs and others are the major end-users of the molecular diagnostic technology. The Clinics and Laboratories are expected to be the fastest-growing end-user type during the forecast period.

Feel free to contact us for any queries - https://univdatos.com/request_form/form/239 

For a deep-dive analysis of the industry, detailed regional/country-level analysis is conducted for markets including North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World). In 2018, North America generated revenue of US$ 2,964.9 million, however, Asia-Pacific is expected to witness the highest CAGR of 6.74%b during the forecast period. The dominance of North America is majorly driven by the presence of a well-established diagnostic infrastructure, technological advancements, patient awareness and presence of advanced products in the field of molecular diagnostics. Some of the major companies profiled in the global Molecular Diagnostics study include Abbott Laboratories, Becton, Dickinson and Company, Biomérieux SA, Danaher Corporation, Hologic, Inc., Qiagen, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific. These industry players are entering into partnerships and mergers & acquisitions to increase their market share. Some of the key players are also expanding their businesses by increasing their expenditure on R&D.

Global Molecular Diagnostics Market Segmentation

Market Insights, by Product

• Instruments
• Reagents

Market Insights, by Technology

• Polymerase Chain Reaction (PCR)
• Transcription-Mediated Amplification (TMA)
• In Situ Hybridization & FISH
• DNA Sequencing & Next-Generation Sequencing (NGS)
• Chips and Microarrays
• Others

Market Insights, by Application

• Microbiology
• Virology
• Hospital Acquired Infections (HAI)
• Genetic Testing
• Oncology
• Pharmacogenetics
• Human Leukocytes Antigen (HLA)
• Blood Screening
• Others

Market Insights, by End User

• Hospitals
• Clinics & Labs
• Other Healthcare Facilities

Market Insights, by Region

• North America Molecular Diagnostics market
  • United States
  • Canada
  • Rest of North America
• Europe Molecular Diagnostics market
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific Molecular Diagnostics market
  • China
  • Japan
  • India
  • Australia
  • Rest of APAC
• Rest of the World Molecular Diagnostics market
  • Brazil
  • Rest of World

UnivDatos Market Insights (UMI) understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Molecular Diagnostics Market can be customized to the country level or any other market segment.

Point of Care Testing Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025

Clinical Nutrition Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020-2026

AI in Healthcare Market Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019–2025

Global In-Vitro Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025

UnivDatos Market Insights (UMI)

Email: sales@univdatos.com

In-Vitro Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast (2019-2025)

Global In-Vitro Diagnostics Market was valued at US$ 68.92 billion in 2018 and is anticipated to reach US$ 98.18 billion by 2025 displaying a reasonable CAGR of 5.24% over the forecast period (2019-2025). Global In-Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to detect infection, diagnose a medical condition, prevent disease and monitor drug therapies. The market of the In-Vitro Diagnostics market is anticipated to grow enormously owing to factors such as rising geriatric population, increasing the prevalence of chronic diseases, increasing adoption of Point-of-care diagnosis, and technology advancement in the In-Vitro Diagnostics technology. Rising demand for Point-of-Care (POC) devices is expected to fuel the market growth in the near future. In addition, the introduction of advanced technologies, such as biochips and nano-biotechnology, and miniaturization of microfluidics are expected to increase the demand for PoC products. These advancements have enabled easy access to PoC diagnostic tests and are likely to facilitate quick and effective test results, thereby boosting the overall market growth. The changing reimbursement models and regulations, investing in unifying technology would mark as a trend in this industry. However, stringent government regulations for the manufacturing of IVD products will act as the major challenges in the growth of this market.

“Reagents dominated the product segment of the global In-Vitro Diagnostics market with 69.0% share in 2018”

Based on Product type the global in-vitro diagnostics market is segmented into reagents and Instruments Services. The market of the Reagents segment is expected to grow tremendously and is projected to dominate the market in 2025 due to its high demand in over-the-counter diagnostic tests, paired with rising demand for these for tests at non-medical facilities such as a home.

Request for Sample of the Report - https://univdatos.com/request_form/form/237 

“Immunoassay technique of In-Vitro Diagnostic dominated the market in 2018”

Based on techniques the global In-Vitro Diagnostics market is segmented into Immunoassay, Clinical Chemistry, SMBG, Molecular Diagnostics, Hematology, Microbiology, Point-of-Care, and Hemostasis. The Immunoassay technique occupied the largest share of 24.7% in 2018 and is expected to maintain its dominance throughout the forecast period 2019-2025. However, Molecular Diagnostics and Point-of-Care testing techniques are expected to witness the highest CAGR growth during the analyzed period, owing to increasing demand for such tests at home.

“In-Vitro Diagnostic technology was majorly applied for the treatment or diagnosis of Infectious Disease”

Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases are the major applications of In-Vitro Diagnostics technology. In 2018, IVD was majorly used for the treatment and diagnosis of Infectious Diseases. The segment is expected to witness CAGR 4.89% during the forecast period 2019-2025 to generate revenue of US$ 33.73 billion by 2025. However, Oncology treatment using IVD is expected to grow at the highest rate during the analyzed period.

For Regional/country-wise analysis of the overall adoption of In-Vitro Diagnostics technology in different healthcare facilities browse through -  In-Vitro Diagnostics Market

“Hospitals were the major end-users of In-Vitro Diagnostic technology in 2018”

Based on end-users, the global In-Vitro Diagnostics market is bifurcated into hospitals, clinics & labs, home care, and other healthcare facilities. In 2018, the hospital segment occupied 47.6% share. However, the use of technology for home disease treatment is expected to witness the highest CAGR growth dusting the forecast period 2019-2025. The growing elderly population and associated diseases would help the segment to witness such growth.

“Reusable IVD Devices are expected to dominate the usability segment of the global in-vitro diagnostics market during the analyzed period.”

In-Vitro Diagnostics market segmented based on usability include reusable and disposable IVD devices. The Reusable IVD Devices occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025.

“North America represents one of the largest markets of the In-Vitro Diagnostics market globally in 2018”

For a deep-dive analysis of the industry and its adoption rate, detailed regional/country-level analysis was conducted for regions including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, UK and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of the World (Brazil and Others). In 2018, North America dominated the market, however, the growing elderly population in Europe and Asia-Pacific would help the region to use more of in-vitro diagnostic technology for disease detection and treatment.

Feel free to contact us for any queries - https://univdatos.com/request_form/form/237 

Competitive Landscape-Top 10 Market Players

Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, Roche, Siemens Healthineers AG, Sysmex Corporation and Thermo Fisher Scientific are some of the prominent players operating in the Global In-Vitro Diagnostics market industry. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products in the In-Vitro Diagnostic sector.

The Global In-Vitro Diagnostics Market can be customized to the country level or any other market segment. Besides this, UnivDatos Market Insights (UMI) understands that you may have your own business need, hence we also provide fully customized solutions to clients.

Global Elderly Care Service Market Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025

Beauty and Personal Care Market — Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020–2026

Molecular Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends & Forecast 2019-2025

UnivDatos Market Insights (UMI)

Email: sales@univdatos.com

Smart Home Technology Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025

The global report on the Smart Home Market published by UnivDatos Market Insights (UMI) anticipates that the market is anticipated to reach a valuation of US$ 170.1 billion by 2025 expanding at a reasonable CAGR of 23.9% in the course of the forecasted period (2019-2025). The global smart home market grew at a CAGR of 17.3% between 2014-2017 periods. The rapid adoption of smart home devices can be attributed to the burgeoning smart device installation, rapid uptake in smartphone penetration and changing the lifestyle of the consumers. Rising demand for comfort and convenience along with the proliferation of the internet of things has considerably surged the demand for smart home devices ranging from energy-efficient solutions, home entertainment devices, lighting control systems, and security systems among other smart appliances. Moreover, with the rising IoT connected devices and enormous demand for technologically advanced solutions, massive opportunity displayed by the Internet of Things has propelled the wireless innovation which has further driven the smart home devices adoption rate. Wifi and Bluetooth have become popular wireless connections to operate the smart home via smart devices. The benefits of smart home technology can also be witnessed extensively among various end-users wherein adoption of the smart home devices has been the game-changer for the residential and commercial end-users. Hence, in 2018, smart appliances including smart washing machines, smart refrigerators, and smart dryers, smart microwaves, and ovens among others held a major share in the Global Smart Home Appliances Market. The segment is anticipated to bring in earnings of US$ 46,713.1 million by 2025.

For a detailed analysis of penetration and adoption of different smart home products browse through - Global Smart Home Market

 Alternatively, under wireless technology, Wi-Fi enabled device is projected to expand rapidly throughout the analyzed period, owing to drastic technological advancements in terms of cloud computing, BYOD and artificial intelligence. Moreover, robust security, reliable connectivity, and other parameters have further influenced the embracement of wireless technology among smart device consumers. Moreover, mid-range house apartments dominated the residential end-user segment with the highest adoption of smart home devices and are expected to remain dominant throughout the forecasted period. The rapid adoption of smart devices among homeowners and renters owing to the benefits that smart devices offer would propel wide adoption of such devices, especially in the developed and developing countries. In addition, disruption is constantly occurring, as smart home technology is gaining prominence among hospitality sector. Hotels, as well as the hospital industry, have also adopted smart devices to deliver quality services to their end customers.

Request for Sample of the report  – https://univdatos.com/request_form/form/205

Growing recognition of economic and operational benefits offered by smart home devices has resulted in the robust growth potential of the technology. Usage of smart home services has significantly benefitted the organizations and enterprises in terms of cost efficiency, energy management along with fostering information technology. Rising demand for energy-saving solutions have dramatically fostered the smart home technology at a global scale. Additionally, information technology has also witnessed explosive growth over the past decades. IoT along with artificial intelligence and increased smartphone penetration has gained wide prominence and continues to attract huge spending. Global IoT spending is anticipated to reach US$ 1.2 trillion by 2022 and worldwide smartphone penetration is expected to hit beyond 50% by 2020. Substantial Surge in adoption of smart home devices ranging from smart speakers, security devices and smart appliances among medium-income consumers has further provided enormous growth opportunities for the companies operating in the smart home technology industry.

Unique variations of smart home technology are bifurcated extensively into applications, technology types, and end-users. Determined by application type, the smart home technology market is bifurcated into safety and security systems, smart appliances, home entertainment, HVAC, lighting and control systems, and energy management systems. By 2025, the smart appliances segment is to command the global smart home market. The segment is projected to bring in sales revenue of US$ 46,713.1 million by 2025. While Wi-Fi, Bluetooth, Zigbee, and Z-Wave are significant wireless services of wireless technology available in the market. Wi-Fi is anticipated to witness rapid adoption and Bluetooth is predicted to enjoy CAGR of 24.2% throughout the forecast period of time. Residential and commercial buildings ranging from luxury homes, mid-range apartments, assisted home, low energy homes, hotels, hospitals are some of the major end-users of smart home technology. Mid-range apartments segment held the major market share in residential smart home end-user segment, wherein assisted homes and low energy homes are conversely anticipated to showcase maximum CAGR during the forecast time period.

Feel free to contact us for any queries – https://univdatos.com/request_form/form/205

Additionally, for better investigation and penetration of smart home technology, the report bifurcates the respective market into distinct landscapes such as North America, Europe, Asia-Pacific, Latin America and the Middle East and North Africa (MENA). In 2017, North America was the largest the market for smart home devices, attributed to the intense competition, innovation paired with the rapid adoption of smart devices across the country such as US and Canada. Moreover, Europe and Asia Pacific are also poised to register drastic advancement in smart home technology throughout the forecast time period attributed to the influx of numerous players, rapid smartphone penetration, growing adoption of smart devices owing to rising need for comfort and energy-saving solutions. Rising disposable income along growing urbanization and smart city initiative was undertaken by government entities in different countries such as China, Japan, and India constitute some of the key catalysts factors towards the wide adoption of smart home devices.

Some of the major companies profiled in the report includes Haier Electronics, ABB Limited, Acuity Brands, Inc., AMX, LLC, ASSA ABLOY, Cisco Systems, Inc., Control4 Corporation, Crestron Electronics Inc., Deutsche Telekom AG, Emerson Electric Co., General Electric Company, Honeywell International Inc., IBM Corporation, LG Electronics Inc., Monitronics International Inc., Schneider Electric S.E., Siemens AG, United Technologies Corporation, Vivint, Inc. and Samsung Electronics. The players consistently aim to focus on product development, launch new products and enhance they're existing portfolios to expand its customer base and strengthen its market position through partnerships and collaborations which further offers them growth opportunities for geographic expansion in the smart home domain. 

Global Smart Home Technology Market Segmentation

Market Insight, by Application

Safety and Security Systems

Smart Appliances

HVAC

Home Entertainment

Lighting Systems

Energy Management

Market Insights, by Technology

Wireless Technology

Wired Technology

Wireless Technology Market Insight, by Technology Type

Wifi

Bluetooth

Zigbee

Z- Wave

Others

Wired Technology Market Insight, by Technology Type

Ethernet

Power Line Communication

Fiber Optics

Others

Market Insights, by End Users

Residential End Users

Commercial End Users

UnivDatos Market Insights (UMI) understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Smart Home Market can be customized to the regional/country level or any other market segment.

Integrated Smart Traffic Control System Market Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020-2026

Global Subscription Ecommerce Market (2019–2025) to Attain Market Value of US$ 487.21 Billion by 2025, Growing at an Exponential CAGR of 68.0%

Electric Vehicle Charging Outlets Market — Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019–2025

Solar Microinverter Market: Current Scenario and Forecast (2019-2025)

UnivDatos Market Insights (UMI)

Email: sales@univdatos.com

In-Vitro Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025

The In-Vitro Diagnostics Market is anticipated to gain the market worth of US$ 98.2 billion by 2025, expanding at a CAGR of 5.24% during the forecast period 2019-2025. The major reasons that would escalate the adoption of In-Vitro Diagnostics are increasing prevalence of chronic diseases, rising geriatric population and increasing adoption of Point-of-Care diagnosis techniques. Moreover, changing reimbursement models and regulations, investing in unifying technology, consolidation and automation of labs, shift to data-driven healthcare would mark as a trend in this industry. In-vitro diagnostics (IVDs) play a critical role in driving clinical decision-making and their true impact includes cost savings and increased efficiencies in downstream activities. IVD testing can answer crucial questions about a patient’s health status, including risk or predisposition for developing a certain condition; stage of disease; chances of therapy response; and prognosis for progression/remission under therapy. Evidence suggests that the potential of IVDs is currently underexploited and undervalued. Recent research indicates that IVDs account for 2.3% and 1.4% of total healthcare expenditure in the US and Germany respectively while driving 66% of clinical decision-making. The reagents segment generated a revenue of US$ 47.5 billion in 2018, owing to the recent advancements in IVD instruments and growth in demand for fully automated instruments in the market.

Request for Sample of the report - https://univdatos.com/request_form/form/237

The growth in the number of public and private diagnostic centers and point-of-care testing centers is expected to fuel growth to the global in-vitro diagnostics market in years to come. Healthcare organizations continue to be challenged with escalating costs and decreased funding, which makes it even more difficult to deliver quality services to a broad patient population. In order to control costs while maintaining a high quality of care, providers are looking to generate efficiency gains, eliminate waste, optimize processes and drive appropriate utilization of resources among others. Chronic diseases are a growing global challenge, and according to WHO estimates, account for approximately 60% of all deaths, worldwide. Hence, an increasing number of Chronic patients demand or In-Vitro Diagnostic technology would increase. Patients are becoming more comfortable with digital devices and services; hence healthcare stakeholders are investing in digital strategies to increase efficiency and improve cost effectiveness of their business and offerings. Integration of technology in labs and hospitals are driving clinicians, data analysts, and corporate leaders, among others, to extract meaningful information from data to deliver higher-quality, more coordinated healthcare services. Accountable care organizations and laboratories emphasize diagnostic testing integrated with hospital systems to harness data while monitoring individual patients. Healthcare is the basic requirement of all the individuals however, high cost of the healthcare service makes it difficult for the low and low-middle class individuals to afford the same. The route to funding and financial aid is extraordinarily complex. Aging leads to deteriorating health due to impairment and thus leads to huge expenditure on it. IVD companies tend to share technologies rather than compete against one another to produce bundled tests, improving the patient care continuum. Technological convergence is bound to increase volume as more patients opt for bundled packages.

Based on Product type the global in-vitro diagnostics market is segmented into reagents and Instruments Services. The market of the Reagents segment is expected to grow tremendously and is projected to dominate the market in 2025 due to its high demand in over-the-counter diagnostic tests, paired with rising demand for these for tests at non-medical facilities such as home. Based on techniques the global In-Vitro Diagnostics market is segmented into Immunoassay, Clinical Chemistry, SMBG, Molecular Diagnostics, Hematology, Microbiology, Point-of-Care and Hemostasis. The Immunoassay technique occupied the largest share of 24.7% in 2018. Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases are the major applications of In-Vitro Diagnostics technology. In 2018, IVD was majorly used for the treatment and diagnosis of Infectious Diseases. The segment is expected to witness CAGR 4.89% during the forecast period 2019-2025. In 2018, hospital segment occupied 47.6% share. However, use of the technology for home disease treatment is expected to witness highest CAGR growth dusting the forecast period 2019-2025. In addition, The Reusable IVD Devices occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025.

Browse Complete Report with TOC - In-Vitro Diagnostics Market

For a deep-dive analysis of the industry and its adoption rate, detailed regional/country-level analysis was conducted for regions including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, UK and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of the World (Brazil and Others). In 2018, North America dominated the market, however the growing elderly population in Europe and Asia-Pacific would help the region to use more of in-vitro diagnostic technology for disease detection and treatment. Some of the major companies profiled in the global In-Vitro Diagnostics study include Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, Roche, Siemens Healthineers AG, Sysmex Corporation and Thermo Fisher Scientific. These industry players are entering into partnerships and mergers & acquisitions for the expansion of their reach and proving older populations with better services. Some of the key players are also expanding their businesses by setting up new elder care homes and community centers or increasing their expenditure on R&D. 

Global In-Vitro Diagnostics Market Segmentation

Market Insights, by Product Type

Reagents

Instruments Services

Market Insights, by Technique

Immunoassay

Clinical Chemistry

SMBG

Molecular Diagnostics

Hematology

Microbiology

Point-of-Care

Hemostasis

Market Insights, by Application

Infectious Disease

Diabetes

Oncology

Cardiology

Nephrology

Autoimmune Disease

Others

Feel free to contact us for any queries - https://univdatos.com/request_form/form/237

The Global In-Vitro Diagnostics Market can be customized to the country level or any other market segment. Besides this UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients.

Beauty and Personal Care Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020-2026

Point of Care Testing Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025

Molecular Diagnostics Market — Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019–2025

UnivDatos Market Insights (UMI)

Email: sales@univdatos.com

Electric Rickshaw Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2025

India has always been home for three-wheelers and similar modes of transportation, as they offer a much needed solution for intercity mobility, which is frequent and affordable. Before the Indian government announced its intention to have an all-electric public transportation fleet by 2030, a three-wheeled electric rickshaw was taking Indian cities by storm. As per a study conducted by Society of manufacturers of electric vehicle, nearly 17 lakhs e-rickshaws have been plying across the Indian cities. In Delhi-NCR alone, the number of electric rickshaws plying on the roads are over 4 lakhs.

At first, electric rickshaw was launched in Delhi during the commonwealth games to provide last mile connectivity to the visitors or spectators going to commonwealth games venue and have presented themselves as an affordable, eco-friendly and convenient mode of mobility. Today, it has spread across the nation, owing to its immense potential of bridging the gap of first and last-mile connectivity. In most urban and semi-urban areas, these battery fitted tricycles are providing the much-required connectivity to the people and are being welcomed by everyday passengers. Today, e-rickshaws are spreading to other Indian cities such as Amritsar, Ahmedabad, Gaya, Patna, Jamshedpur, Cuttack, Kochi, Hyderabad etc. to offer a proper para-transit solution for connecting nearby places. However, the lack of proper regulation such as the registration of these vehicles has triggered the concern for the authorities as most of them plying on the roads have not been registered with the governing authorities. Additionally, the sporadic growth of e-rickshaws also creates problems like traffic congestion as the speed of these vehicles is limited to 25Kmph and don’t have proper parking stands.

Request for Sample of the report  - https://univdatos.com/request_form/form/162

The spread and acceptance of the e-rickshaws became inevitable. Further, the government is also working towards encouraging and accelerating the adoption of electric vehicles in the public transport system in India, which is also expected to accelerate the Indian e-rickshaw market in the near future. On average, it is expected that as many as 10,000 new e-rickshaws would be entering the Indian market every month while the annual sales would increase by 9.1% during the forecast period. With increasing government focus on promoting electric vehicle usage and offering subsidies and tax relaxation, it is believed that India e-rickshaw market will witness unprecedented growth. E-rickshaw is a boon to the commuters as well as for the environment. E-rickshaws have become one of the preferred modes of public transport for passengers and are gaining popularity as they are alternative to petrol, diesel or CNG driven vehicles. E-rickshaw is a battery-powered vehicle, which can run 90-100 km on full charge at a top speed of 25 km/hour. In India, majority of e-rickshaw runs on Sealed Lead Acid (SLA) battery as it is cheaper while nowadays, the market for Li-ion battery is gaining popularity due to its benefits. The Li-ion battery gets charged in less time in comparison to the lead-acid battery and also needs less maintenance. Owing to its benefits, it is expected that in Indian e-rickshaw market, Li-ion the battery market is growing significantly with a CAGR of more than 12% over the forecast period.

The number of electric vehicles are growing in India and so does the e-rickshaw but the lack of an adequate charging infrastructure across the country is hindering the possible growth of the e-rickshaw market. The difficulties in finding the charging stations/points for charging the e-rickshaw and uncertainty over being able to charge the battery is said to be holding back the sales of e-rickshaw. Coupled with this, the lack of availability of sufficiently accessible charging points for public use and proper parking stands further restrain Indian e-rickshaw market. Typically, e-rickshaws are built to carry passengers, however, with increasing awareness regarding its nature i.e. cost-efficient and eco-friendly, e-loader is also gaining popularity in the Indian market for carrying goods. The majority of the e-rickshaw market is held by passenger carriers. On the other hand, with the increasing usage of e-loader for carrying goods, garbage, cartons, water bottles, etc., it is expected that this segment would grow at a CAGR of more than 10% during the analyzed period.

Browse Complete Report with TOC - India E-Rickshaw Market

Indian e-rickshaw market is very much fragmented. A large number of organized and unorganized players are operating in the Indian e-rickshaw market. However, the majority of share is held by unorganized players as these players import e-rickshaw parts from China and assemble them at their manufacturing units. The price of an e-rickshaw is very much competitive and is ranged between INR 90,000-1,10,000. Some of the prominent players operating in the Indian e-rickshaw market include Terra Motors, Atul Auto, Lohia Auto, Hero Electric, Electrothermal, Mahindra & Mahindra, Saera Auto and OK Play. These players are consistently working to meet the growing consumer demand and strengthen their market position which further offers them growth opportunities for regional expansion in the e-rickshaw industry in India.

India E-Rickshaw Market

Market Insights by Vehicle Type

• Passenger Carrier
• Load Carrier

Market Insights by Battery Type

• Sealed Lead Acid (SLA)
• Li-ion

Market Insights by Ownership

• Owned E-Rickshaw
• Rented E-Rickshaw

Feel free to contact us for any queries - https://univdatos.com/request_form/form/162

India E-Rickshaw Market can be customized to the state level or any other market segment. Besides this, UnivDatos Market Insights (UMI) understands that you may have your own business need, hence we also provide fully customized solutions to clients.

Integrated Smart Traffic Control System Market - Current Analysis and Forecast (2020-2026)

Head-up Display Market to witness steady growth at CAGR of 23.3% during the forecast period 2019-2025

Advanced Driver Assistance Systems (ADAS) Market — Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020–2026

UnivDatos Market Insights (UMI)

Email: sales@univdatos.com